A preparation method of telmisartan intermediate
By using a large polar solvent to perform one-pot acylation and cyclosynthesis reaction in the presence of an acylating agent, the problems of high energy consumption and long reaction time in the preparation process of the existing telmisartan intermediate are solved, and high purity is achieved. High yield and environmentally friendly preparation method, suitable for industrial production.
Patent Information
- Application Number
- CN202111356593.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-16
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-11-16
AI Technical Summary
The existing preparation process of telmisartan intermediates has problems of high energy consumption, long reaction time, low yield and high cost, and produces a large amount of phosphorus-containing wastewater and heat, affecting environmental friendliness.
Under enzymatic conditions, the pH value is adjusted to precipitate solid by using a large polar solvent and acylating agent under enzymatic conditions, and the solid is obtained by filtration to obtain a high-purity telmisartan intermediate, avoiding phosphorus-containing solvents. The use of the reaction time is shortened and the yield is improved.
It realizes the preparation of telmisartan intermediates with simple operation, short reaction time, high purity, high yield and environmentally friendly, which reduces the production of wastewater and heat, which is suitable for industrial production.
Smart Images

Figure BDA0003357765930000011 
Figure BDA0003357765930000021 
Figure BDA0003357765930000022
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pharmaceutical chemistry and relates to a method for preparing a telmisartan intermediate, in particular to a method for preparing a telmisartan intermediate 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole. Background Art
[0002] Telmisartan (Formula VI) is a new type of antihypertensive drug, a specific angiotensin II receptor (ATⅠ type) antagonist, used to treat essential hypertension. It replaces the angiotensin II receptor and binds with high affinity to the ATⅠ receptor subtype (known angiotensin II action site). Telmisartan has no agonist effect at any site of the ATⅠ receptor site, selectively binds to the ATⅠ receptor, and the binding effect is long-lasting. It has no affinity for other receptors (including AT2 and other AT receptors with fewer characteristics).
[0003] At present, the main synthetic route of telmisartan is:
[0004]
[0005] Compound I (chemical name: 2-n-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl)benzimidazole) is reacted with compound IV (R is selected from methyl, ethyl, isopropyl) to generate telmisartan medoxomil (Formula V), which is then hydrolyzed to generate telmisartan, and recrystallized to obtain the finished telmisartan.
[0006] Compound I is an important intermediate for the synthesis of telmisartan. The commonly used method is to use 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole (Formula II) and N-methyl-o-phenylenediamine hydrochloride (Formula III) as starting materials, and to undergo a high-temperature cyclization reaction at 150°C to 155°C in the presence of polyphosphoric acid (PPA) or phosphorus pentoxide. The synthesis route is as follows:
[0007]
[0008] Whether polyphosphoric acid or phosphorus pentoxide is used, a large amount of phosphorus-containing wastewater will be generated. In addition, polyphosphoric acid is used as both a solvent and a reactant, and the amount is large. Due to its high viscosity, stirring is difficult in industrial production. The product after the reaction is dissolved in the solution, and it is necessary to neutralize it with alkali to obtain the crude product of the target product, resulting in a large amount of three wastes; and phosphorus pentoxide will release a large amount of heat during the reaction, which is dangerous for material impact, and a large amount of alkali is also required for neutralization after the reaction, resulting in a large amount of three wastes. Moreover, whether polyphosphoric acid or phosphorus pentoxide is involved in the reaction, it generally takes more than 10 hours to react completely, the reaction time is long, and the energy consumption is high. Finally, the crude purity of the compound I obtained by using polyphosphoric acid or phosphorus pentoxide to participate in the reaction is poor, and it needs to be refined for many times to reach more than 99% purity, which is costly and has a low yield (≤70%). Summary of the invention
[0009] The purpose of the present invention is to provide a preparation method of a telmisartan intermediate (i.e., 2-n-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl)benzimidazole) with simple operation, short reaction time, high purity, high yield, environmental friendliness and suitability for industrial production, in view of the problems existing in the existing process of the telmisartan intermediate.
[0010] The technical solution of the present invention is:
[0011] A method for preparing a telmisartan intermediate comprises the following steps:
[0012] Step (1), using a highly polar solvent as a reaction solvent, 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole (Formula II) and N-methyl-o-phenylenediamine hydrochloride (Formula III) as reaction raw materials, and reacting in the presence of an acylating agent to obtain a reaction solution containing compound I;
[0013] Step (2), adjusting the pH of the reaction solution to 5-10 with a base, precipitating a solid, and filtering to obtain the telmisartan intermediate shown in formula I.
[0014]
[0015] In step (1), the molar ratio of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole to N-methyl-o-phenylenediamine hydrochloride is 1.0:0.5 to 1.0:4.0, preferably 1.0:1.1 to 1.0:4.0, and more preferably 1.0:2.0 to 1.0:4.0.
[0016] The highly polar solvent is one or more of N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), N-methylpyrrolidone, tetrahydrofuran (THF), and 1,4-dioxane; preferably N-methylpyrrolidone.
[0017] The acylating agent is an organic acyl halide or an inorganic acyl halide, preferably oxalyl chloride, benzoyl chloride, thionyl chloride, etc.
[0018] The molar ratio of the acylating agent to 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole is 0.8:1.0 to 10.0:1.0, preferably 0.8:1.0 to 5.0:1.0, and more preferably 0.8:1.0 to 1.5:1.0.
[0019] The reaction temperature is 40°C to the reflux temperature of the system.
[0020] Specifically, the method comprises: dissolving 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole in a reaction solvent, adding thionyl chloride dropwise under stirring, and after the addition is completed, heating to 40-60° C. to react for 1-3 hours; then adding N-methyl-o-phenylenediamine hydrochloride, and reacting at 40° C. to the system reflux temperature for 3-4 hours.
[0021] In step (2), as a further preferred technical solution, water in an amount 1 to 2 times the volume of the reaction solvent is added to the reaction solution, and then a base is used to adjust the pH to 5 to 10. Water is a poor solvent, and alkalization after adding water can cause the product to crystallize; if the pH is lower than 5, the yield will be reduced, and if the pH is higher than 10, impurities will precipitate.
[0022] The alkali is one of sodium hydroxide or its solution, potassium hydroxide or its solution, sodium carbonate or its solution, potassium carbonate or its solution, sodium bicarbonate or its solution, potassium bicarbonate or its solution, and ammonia water (including gaseous form).
[0023] Beneficial effects of the present invention:
[0024] (1) The present invention adopts a synthetic reaction route with a completely new mechanism, avoids the use of phosphorus-containing solvents and reagents, and the raw and auxiliary materials are readily available and cheap in the market. It only involves the use of one organic solvent, which can be recycled and reused, and is a green and environmentally friendly process;
[0025] (2) Compared with the existing method which requires at least two reaction steps or a high temperature reaction time of more than 10 hours, the one-pot acylation and cyclization reaction of the present invention only takes 1 to 4 hours, which has lower manufacturing cost and is more suitable for production;
[0026] (3) The total molar yield of the present invention is above 90%, and the purity is above 99%, which is significantly higher than the yield of the existing process (≤70%), and a high-purity target product can be obtained without refining, and the cost of raw materials is lower, which is more conducive to the marketization of the product. DETAILED DESCRIPTION
[0027] The technical solution of the present invention is further described below through specific implementation methods.
[0028] Example 1
[0029] 218 g (1.0 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of N,N-dimethylformamide were added to a 3L reaction bottle, and 94 g (0.8 mol) of thionyl chloride was added dropwise under stirring. After the addition was completed, the temperature was raised to 40°C for reaction for 3 h; 98 g (0.5 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to 135°C for reaction for 3 h, the temperature was lowered to room temperature, 200 mL of water was added to the system, the pH was adjusted to 5 with 30% sodium hydroxide solution, the mixture was stirred at room temperature for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 291 g of an off-white solid, i.e., 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 91% and a HPLC purity of 99.5%.
[0030] Characterization data of 2-n-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl)benzimidazole:
[0031] 1 H NMR (500MHz, DMSO) δ: 1.02 (t, J = 8Hz, 3H), 1.89 (m, 2H), 2.6 (s, 3H), 2.89 (t, J = 8Hz, 2H), 3.93(s,3H), 7.27~7.31(m,3H), 7.47(s,1H), 7.61~7.71(m,2H), 7.78(s,1H).
[0032] LC-MS (ESI) m / z: 305.1 (M+H) + .
[0033] Example 2
[0034] 100 g (0.46 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of N-methylpyrrolidone were added to a 2L reaction bottle, and 81 g (0.69 mol) of thionyl chloride was added dropwise under stirring. After the addition was complete, the temperature was raised to 40°C for reaction for 3 h; 358 g (1.84 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to reflux for reaction for 4 h, the temperature was lowered to room temperature, 300 mL of water was added to the system, the pH was adjusted to 6 with concentrated ammonia water, the mixture was stirred for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 141 g of a white solid, i.e. 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 96% and a HPLC purity of 99.9%.
[0035] Example 3
[0036] 100 g (0.46 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of dimethyl sulfoxide were added to a 2L reaction bottle, and 81 g (0.69 mol) of thionyl chloride was added dropwise under stirring. After the addition was completed, the temperature was raised to 40°C for reaction for 3 h; 358 g (1.84 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to reflux for reaction for 4 h, the temperature was lowered to room temperature, 300 mL of water was added to the system, the pH was adjusted to 6 with concentrated ammonia water, the mixture was stirred for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 132 g of a white solid, i.e. 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 90% and a HPLC purity of 99.6%.
[0037] Example 4
[0038] 100 g (0.46 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of N-methylpyrrolidone were added to a 2L reaction bottle, and 87 g (0.69 mol) of oxalyl chloride was added dropwise under stirring. After the addition was complete, the temperature was raised to 40°C for reaction for 3 h; 358 g (1.84 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to reflux for reaction for 4 h, the temperature was lowered to room temperature, 300 mL of water was added to the system, the pH was adjusted to 6 with concentrated ammonia water, the mixture was stirred for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 133 g of a white solid, i.e. 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 91% and a HPLC purity of 99.5%.
[0039] Example 5
[0040] 100 g (0.46 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of N-methylpyrrolidone were added to a 2L reaction bottle, and 81 g (0.69 mol) of thionyl chloride was added dropwise under stirring. After the addition was complete, the temperature was raised to 40°C for reaction for 3 h; 88 g (0.46 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to reflux for reaction for 4 h, the temperature was lowered to room temperature, 300 mL of water was added to the system, the pH was adjusted to 6 with concentrated ammonia water, the mixture was stirred for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 132 g of a white solid, i.e. 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 90% and a HPLC purity of 99.6%.
[0041] Example 6
[0042] To a 3L reaction bottle, 200g (0.92mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 600mL of dimethyl sulfoxide were added, and 541g (4.59mol) of thionyl chloride was added dropwise under stirring. After the addition was completed, the temperature was raised to 40°C for reaction for 3h; 196g (1.0mol) of N-methyl-o-phenylenediamine hydrochloride was added, and the reaction was carried out at 40°C for 4h. The temperature was lowered to 30°C, 1200mL of water was added to the system, the pH was adjusted to 7 with 20% sodium hydroxide solution, the temperature was kept at 30°C and stirred for 2h, filtered, and dried under reduced pressure at 60°C to obtain 278g of an off-white solid with a molar yield of 90% and an HPLC purity of 99.2%.
[0043] Example 7
[0044] 150g (0.69mol) 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 750ml 1,4-dioxane were added to a 3L reaction bottle, and 117g (0.88mol) oxalyl chloride was added dropwise under stirring. After the addition was completed, the temperature was raised to 60°C for reaction for 1h. 150g (0.77mol) N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to 120°C for reaction for 6h, the temperature was lowered to 80°C, 1400mL water was added to the system, the pH was adjusted to 8 with 30% sodium hydroxide solution, the temperature was lowered to 40°C, the temperature was kept stirred for 4h, filtered, and dried under reduced pressure at 70°C to obtain 210g of off-white solid, with a molar yield of 95% and a HPLC purity of 99.3%.
[0045] Example 8
[0046] 150g (0.69mol) 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 750mL tetrahydrofuran were added to a 3L reaction bottle, and 148g (1.05mol) benzoyl chloride was added dropwise under stirring. After the addition was completed, the temperature was raised to 50°C for reaction for 1h. 150g (0.77mol) N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to 70°C for reaction for 6h, the temperature was lowered to 30°C, 1400mL water was added to the system, the pH was adjusted to 6 with 30% sodium hydroxide solution, the mixture was stirred for 4h, filtered, and dried under reduced pressure at 80°C to obtain 208g of a white solid with a molar yield of 94% and a HPLC purity of 99.5%.
[0047] Example 9
[0048] 100 g (0.46 mol) of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 200 mL of N-methylpyrrolidone were added to a 2L reaction bottle, and 81 g (0.69 mol) of thionyl chloride was added dropwise under stirring. After the addition was complete, the temperature was raised to 40°C for reaction for 3 h; 179 g (0.92 mol) of N-methyl-o-phenylenediamine hydrochloride was added, the temperature was raised to reflux for reaction for 4 h, the temperature was lowered to room temperature, 300 mL of water was added to the system, the pH was adjusted to 6 with concentrated ammonia water, the mixture was stirred for 2 h, filtered, and dried under reduced pressure at 60°C to obtain 142 g of a white solid, i.e. 2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole, with a molar yield of 97% and a HPLC purity of 99.9%.
[0049] Comparative Example 1
[0050] Add 140g 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and 595g PPA into a 3L reaction bottle, heat to 100°C, add 131g N-methyl-o-phenylenediamine hydrochloride, heat to 155°C, keep warm for 18 hours, cool to 100°C, add 900g water, control the temperature ≤10°C, add 1800g ammonia water dropwise to adjust the pH to 8, stir and crystallize at 0-10°C for 2 hours, centrifuge, and wash with water to pH = 7.
[0051] Add 300 g of hydrochloric acid to the crude telmisartan intermediate, stir to dissolve, crystallize at 0-5°C for 18±2 hours, centrifuge, and set the filtrate aside. Add 1200 g of water to dissolve the filter cake, decolorize it with 15 g of activated carbon 4 times, filter it, and dry it under reduced pressure at 80°C to obtain 147 g of an off-white solid.
[0052] The above purification steps were repeated to finally obtain 134 g of an off-white solid with a molar yield of 65% and a HPLC purity of 97.2%.
[0053] Comparative Example 2
[0054] Add 210g of methanesulfonic acid to the reaction bottle, heat to 80°C, add 70g of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole, control the temperature at 85°C to 95°C, add 62g of N-methyl-o-phenylenediamine hydrochloride; heat to 110°C to 130°C, slowly add 210g of phosphorus pentoxide, control the temperature not to exceed 150°C during the addition, after the addition is completed, react at 140°C to 150°C for 3h, cool to 100°C, add 1000mL of water, adjust the pH to 7 with 50% sodium hydroxide solution, filter, and obtain a crude telmisartan intermediate.
[0055] The crude telmisartan intermediate was added to a reaction bottle, and 700 ml of ethyl acetate was added. The temperature was raised to 80°C, and the solution was filtered after dissolving. The filtrate was cooled to 0-5°C, stirred for 3 hours, filtered, and the filter cake was dried under reduced pressure at 80°C to obtain 62 g of an off-white solid with a molar yield of 60% and a HPLC purity of 97.9%.
[0056] Table 1. Comparison between the method of the present invention and the existing process
[0057] Yield purity Total wastewater Phosphorus-containing wastewater Example 2 ≥90% ≥99% 8kg / kg none Comparative Example 1 65% 97.2% 46kg / kg 23kg / kg Comparative Example 2 60% 97.9% 25kg / kg 25kg / kg
Claims
1. A method for preparing a telmisartan intermediate, characterized in that: The following steps are involved: Step (1), using 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole and N-methyl-o-phenylenediamine hydrochloride as reaction raw materials, dissolving 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole in a reaction solvent, adding an acylating agent dropwise under stirring, and heating to 40-60° C. for reaction for 1-3 hours; then adding N-methyl-o-phenylenediamine hydrochloride, reacting at 40° C. to the reflux temperature of the system for 3-4 hours to obtain a reaction solution containing compound I; the reaction solvent is one or more of N,N-dimethylformamide, dimethyl sulfoxide, N-methylpyrrolidone, tetrahydrofuran, and 1,4-dioxane; Step (2), adding water in an amount 1 to 2 times the volume of the reaction solvent to the reaction solution, and then adjusting the pH of the reaction solution to 5 to 10 with a base, precipitating a solid, and filtering to obtain a telmisartan intermediate shown in Formula I; 2. The method for preparing a telmisartan intermediate according to claim 1, wherein: In step (1), the molar ratio of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole to N-methyl-o-phenylenediamine hydrochloride is 1.0:0.5 to 1.0:4.
0.
3. The method for preparing a telmisartan intermediate according to claim 2, wherein: In step (1), the molar ratio of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole to N-methyl-o-phenylenediamine hydrochloride is 1.0:1.1 to 1.0:4.
0.
4. The method for preparing a telmisartan intermediate according to claim 3, wherein: In step (1), the molar ratio of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole to N-methyl-o-phenylenediamine hydrochloride is 1.0:2.0 to 1.0:4.
0.
5. The method for preparing a telmisartan intermediate according to claim 1, wherein: In step (1), the acylating agent is an organic acyl halide or an inorganic acyl halide.
6. The method for preparing a telmisartan intermediate according to claim 5, characterized in that: In step (1), the acylating agent is oxalyl chloride, benzoyl chloride, or thionyl chloride.
7. The method for preparing a telmisartan intermediate according to claim 1, 5 or 6, characterized in that: In step (1), the molar ratio of the acylating agent to 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole is 0.8:1.0 to 10.0:1.
0.
8. The method for preparing a telmisartan intermediate according to claim 7, wherein: In step (1), the molar ratio of the acylating agent to 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole is 0.8:1.0 to 5.0:1.
0.
9. The method for preparing a telmisartan intermediate according to claim 8, characterized in that: In step (1), the molar ratio of the acylating agent to 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole is 0.8:1.0 to 1.5:1.
0.
10. The method for preparing a telmisartan intermediate according to claim 1, characterized in that: In step (2), the alkali is one of sodium hydroxide or its solution, potassium hydroxide or its solution, sodium carbonate or its solution, potassium carbonate or its solution, sodium bicarbonate or its solution, potassium bicarbonate or its solution, and ammonia water.
